Replies to post #91675 on Ocata Therapeutics Inc fka OCAT

[elysse1kittycat]

"Something good is happening i can feel it in my bones."

There is something and has always been something very evil and corrupt about the company in the self serving manner in which it has been run.
Sadly this pervasive,,everlasting and stifling stench is one of the big reasons why no American Pharmaceutical Company wants to be associated with Ocata.
Thankkfully Astellas has come to the rescue and hopefully this deal will go through for the good of those afflicted and shareholders.

[Dragon Lady]

Quote LOL, "Something good is happening i can feel it in my bones.
"

Yep. OCATA is getting SOLD for exactly $8.50 a share to a Japanese mega-pharma with deep pockets in a perfectly normal, 100% moving forward, Tender offer.

It's "good" and the best thing that could ever happen to this lucky little cash poor dilution machine OTC convert company. Many, many shareholders feel it in their bones, how good the Astellas Tender offer really is for OCATA. The OCATA BOD and entire Sr Mgt team felt it in their bones that it was so good they all signed unanimously to accept this spectacularly good and lucky offer to come along at such a premium as $8.50 a share.

Getting a 79% premium on their shares is an incredibly "good" and lucky thing and the OCATA Board of Directors and all their Sr Mgt (including the company genius, the brilliant Dr. Lanza who's tendering all of his approx 200K of his shares to Astellas already) - voted unanimously for it and think it's FANTASTIC, not just good.

Totally agree, the Tender offer is good, it's FANTASTIC for this little company that was going to enter 2016 once again on life support with low cash in a time now of tightening capital markets, no phase II advancing (a YEAR late already now) and no revenues and no products and NO prospects of any for YEARS (5 at least) to come if ever per their own SEC filings, and another year of really no progress, but another qtr ending in a few days in which approx $6 MILLION more will be gone off their cash-line balance sheet entry.

Wonderful for the vast majority of OCATA shareholders who will win out with the Astellas Tender offer and eventual merger as it progresses 100% normal through a 1st extension, a perfectly normal part of the process of how Tender offers "work".